Visiomed Group SA
PAR:ALVMG
Net Margin
Visiomed Group SA
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| FR |
|
Visiomed Group SA
PAR:ALVMG
|
50.8m EUR |
7%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
234.9B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.6B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
147.5B USD |
12%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
144.2B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.9B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
51.2B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49.4B USD |
7%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.2B USD |
75%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.2B USD |
23%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
287.7B CNY |
31%
|
Visiomed Group SA
Glance View
Visiomed Group SA engages in the development and distribution of healthcare products and services. The company is headquartered in Puteaux, Ile-De-France. The company went IPO on 2011-07-05. The firm is primarily engaged in the design, manufacture and marketing of medical electronics. The company develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The firm's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The firm serves pharmacies, health professionals, hospitals, clinics and retirement homes. The company also offers connected solutions and COVID devices such as deconfinement kits, masks, filter cushion, serological tests etc. The Company’s subsidiaries include ThermoFlash and BewellConnect.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Visiomed Group SA's most recent financial statements, the company has Net Margin of 6.6%.
You don't have any saved screeners yet